- Report
- July 2025
- 183 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- April 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- March 2025
- 200 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- April 2025
- 135 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 197 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 185 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 192 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- August 2025
- 182 Pages
Global
From €3450EUR$3,939USD£2,994GBP
- Report
- February 2025
- 182 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- February 2026
- 171 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- April 2024
- 620 Pages
Global
From €6131EUR$7,000USD£5,321GBP
- Report
- April 2023
- 600 Pages
Global
From €5255EUR$6,000USD£4,561GBP
From €1226EUR$1,400USD£1,064GBP
- Report
- May 2024
- 123 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- May 2023
- 140 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- March 2024
- 102 Pages
Middle East, Africa
From €3022EUR$3,450USD£2,623GBP
- Report
- June 2023
- 86 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- September 2025
Global
From €3065EUR$3,500USD£2,661GBP

The Point-of-Care (POC) Coagulation Test market is a subset of the larger Point-of-Care Diagnostics market. It is focused on the development and sale of devices and tests that measure the clotting ability of a patient's blood. These tests are used to diagnose and monitor a variety of conditions, including deep vein thrombosis, pulmonary embolism, and stroke. POC Coagulation Tests are typically small, portable, and easy to use, allowing for quick results in a variety of settings. They are also cost-effective, making them attractive to healthcare providers.
Notable companies in the POC Coagulation Test market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, and Sysmex Corporation. Show Less Read more